Bio-Techne Corporation
TECH
$62.29
-$1.54-2.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.59% | 0.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.59% | 0.25% | |||
| Cost of Revenue | -8.93% | 4.68% | |||
| Gross Profit | -9.93% | -1.84% | |||
| SG&A Expenses | 86.62% | -55.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.32% | -25.66% | |||
| Operating Income | -63.86% | 158.05% | |||
| Income Before Tax | 309.94% | -159.72% | |||
| Income Tax Expenses | 289.27% | -133.03% | |||
| Earnings from Continuing Operations | 316.00% | -178.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 316.00% | -178.26% | |||
| EBIT | -63.86% | 158.05% | |||
| EBITDA | -53.63% | 97.02% | |||
| EPS Basic | 314.87% | -179.65% | |||
| Normalized Basic EPS | -64.21% | 167.65% | |||
| EPS Diluted | 306.36% | -183.07% | |||
| Normalized Diluted EPS | -64.22% | 168.93% | |||
| Average Basic Shares Outstanding | 0.36% | -1.56% | |||
| Average Diluted Shares Outstanding | 0.39% | -2.01% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 1.47% | -2.26% | |||